Navigation Links
Powerful technique for multiplying adult stem cells may aid therapies

Adult stem cells may be free of the ethical concerns that hamper embryonic stem cell research, but they still pose formidable scientific challenges. Chief among these is the doggedness with which adult stem cells differentiate into mature tissue the moment they're isolated from the body. This makes it nearly impossible for researchers to multiply them in the laboratory. And because adult stem cells are so rare, that makes it difficult to use them for treating disease.

Now, researchers in the lab of Whitehead Institute Member and MIT professor of biology Harvey Lodish have discovered a way to multiply an adult stem cell 30-fold, an expansion that offers tremendous promise for treatments such as bone marrow transplants and perhaps even gene therapy.

"A 30-fold increase is ten times higher than anyone's achieved before," says Lodish, senior author on the paper, which will be published January 22 online in Nature Medicine.

Unlike embryonic stem cells, adult stem cells are generally tissue-specific, each one destined to develop into several kinds of cells. Chengcheng Zhang, a postdoctoral researcher in the Lodish lab, was determined to develop a way to multiply adult stem cells once they've been isolated from tissue. Achieving this goal required some intricate laboratory sleuthing.

Zhang began by studying adult hematopoietic--blood cell forming--stem cells. Offspring of some of these cells develop into all of the red and white blood cells, while others form the immune system. Using fetal tissue from mice as the source of these cells, Zhang discovered a population of cells that were not stem cells, yet appeared to interact with stem cells, preserving and allowing them to multiply in the fetal environment. When he isolated the stem cells in the lab and cultured them in a dish by themselves, they died. When he mixed them with these newly discovered cells, they thrived. But how did these new cells manage to sustain the stem cells so
'"/>

Source:Whitehead Institute for Biomedical Research


Page: 1 2 3

Related biology news :

1. Powerful new tool for studying brain development
2. Powerful genome ID method extended to humans
3. New lab technique identifies high levels of pathogens in therapy pool
4. Brain-mapping technique aids understanding of sleep, wakefulness
5. Study reveals new technique for fingerprinting environmental samples
6. Researchers pioneer new gene therapy technique using natural repair process
7. Newer imaging techniques may lead to over-treatment
8. Gene silencing technique offers new strategy for treating, curing disease
9. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
10. Researchers devise new technique for creating human stem cells
11. New technique rapidly detects illness-causing bacteria

Post Your Comments:
(Date:11/26/2009)...vember 26, 2009) Whitehead researchers have devel...to pinpoint specific genes and proteins used by pa... In most human cell cultures genes are present in... from the mother. Gene inactivation by mutation is...activated, the second copy usually remains active ...
(Date:11/25/2009)...roduced in the stomach, may be used to boost resis...disease, Yale School of Medicine researchers repor...ournal of Neuroscience . , Parkinson,s disease i...an area of the midbrain known as the substantia ni... Reduced production of dopamine in late-stage Par...
(Date:11/25/2009)...R 25, 2009 Soil is the linchpin of the environmen...et. Despite that, many students see soil as "just ...oil science educators are challenged with the task...critical importance of soil in the environment. ,...th science teachers at University of Nebraska-Linc...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 1New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 2New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 3New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 4New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 5New Shape HF 26amp 3B 238482 3B Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting 48399 1New Shape HF 26amp 3B 238482 3B Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting 48399 2New Shape HF 26amp 3B 238482 3B Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting 48399 3Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Car 4580 1
... be exhausting. When fruit flies mate, the females...s when an immune reaction starts. This is shown in...ng in the scientific publication, Journal of Evol...avioral studies and genomic technology, so-called ... show how fruit fly females are affected by mating...
...ase is available in French . , Montreal, Febru... life has been resolved. According to a study publ...ntral scientists have proposed a new theory for ho...aged to self-assemble as a critical step in the ge... is a complex structure it features a clear hierar...
...Observatory of Singapore (EOS) which aspires to be... addressing several of civilisation,s most serious...namis, volcanic eruptions and climate change aims...ocus on Southeast Asia, that could potentially sav...highly anticipated first Research Centre of Excell...
Other Biology News:Life secret exposed: Scientists unlock mystery of molecular machine 2The Earth Observatory of Singapore devoted to the study of earth sciences officially opens 2The Earth Observatory of Singapore devoted to the study of earth sciences officially opens 3
(Date:11/24/2009)...nt bank KTA Capital,s client Neuren Pharmaceutical...le note private placement with a U.S. institutiona...KTA Capital as Neuren,s exclusive placement agent ...PRWEB) November 23, 2009 -- The independent New Yo...ital") has announced that its client Neuren P...
(Date:11/24/2009)...irstCall/ -- Sigma-Aldrich Corporation (Nasdaq: S...nce on Tuesday, December 1st at 1:45 PM GMT in Lon... via live audio broadcast over the Internet availa...com/ . Users can click the "Webcast" icon to acc...gma-Aldrich is a leading Life Science and High Tec...
(Date:11/24/2009)...ewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NG...oping and commercializing novel pain management th...sident and Chief Executive Officer, is scheduled t...Care Conference, to be held December 1-2, 2009 at ...,, Mr. DiTonno and Stephen Ghiglieri, Chief Fin...
(Date:11/24/2009)... been met for patients with advanced-stage, or ...Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris ... global biopharmaceutical company focused on endoc...e efficacy data from a Phase 2 study with its targ...ly AN-152), in patients with advanced or recurrent...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...American Association for Cancer Research ...il 15 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX )...from its,registrational bioequivalence clinical st...American Association for Cancer Research (AACR),An...harmacokinetic,equivalence observed between an emu...
...Trust, Inc.,(NYSE: BMR ) today announced that Mar...ncurrently with the company,s annual meeting of st..., the Ernest W. Hahn Professor of Real Estate Fina...enter for Real Estate at the,University of San Die...rectors since its initial public offering in 2004,...
...ting Late-Breaking Clinical Trials ...IEGO, April 14 ,Medivation, Inc. (Nasdaq: MDVN ) ...2 clinical trial showed that the Company,s novel a... reduce serum levels of prostate specific,antigen ...anded dose group,tested after three months of trea...
Other Biology Technology:ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 2ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 3ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 4ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 5BioMed Realty Trust Announces Retirement of Mark Riedy From Its Board of Directors 2BioMed Realty Trust Announces Retirement of Mark Riedy From Its Board of Directors 3Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients 3
...ip arrays have been developed for affinity capture... ProteinChip chemical surfaces allow differential ...hemical properties. Each chip has eight different ...d the chips are color-coded with a unique hydropho...
Thermal Printer, 120 V from Bio-Rad
...Assay with FAM-Labeled Substrate (green fluorescen...e serine protease activation • No lysing, fix...its utilize cell-permeable, fluorescently labeled ... chymotrypsin-like activity in whole living cells....
...ay systems, known as ChemiArrayTM Mouse Cytokine A...ith current methodologies. Besides the ability to ...nt a more accurate reflection of active cytokine l... and no amplification step is needed. Furthermore,...
Biology Products: